You are here

Funding Opportunities

Teva Pharmaceuticals, The ALS Association, The Huntington’s Disease Society of America
Submission Deadline:
29 Apr 2018
US National Institutes of Health
Cycle II due date:
25 May 2018
National Institute on Drug Abuse
Cycle I due date:
5 Sep 2018